BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36210485)

  • 21. Positive selection and high sensitivity test for MYD88 mutations using locked nucleic acid.
    Albitar A; Ma W; DeDios I; Estella J; Agersborg S; Albitar M
    Int J Lab Hematol; 2016 Apr; 38(2):133-40. PubMed ID: 26797804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Validation of a CXCR4 Mutation Screening Assay for Waldenstrom Macroglobulinemia.
    Ballester LY; Loghavi S; Kanagal-Shamanna R; Barkoh BA; Lin P; Medeiros LJ; Luthra R; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):395-403.e1. PubMed ID: 27268124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYD88
    Ferrante M; Furlan D; Zibellini S; Borriero M; Candido C; Sahnane N; Uccella S; Genuardi E; Alessandria B; Bianchi B; Mora B; Grimaldi D; Defrancesco I; Jiménez C; Cavallo F; Ferrero D; Dogliotti I; Merli M; Varettoni M; Ferrero S; Drandi D
    Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33926007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Tools of Waldenströms Macroglobulinemia - Best Possibilities for Non-invasive and Long-term Disease Monitoring.
    Growkova K; Kufová Z; Sevcikova T; Filipová J; Kascak M; Jelínek T; Grosicki S; Barchnicka A; Roziaková Ľ; Mistrík M; Simicek M; Hájek R
    Klin Onkol; 2017; 30(Supplementum2):81-91. PubMed ID: 28903575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.
    Treon SP; Cao Y; Xu L; Yang G; Liu X; Hunter ZR
    Blood; 2014 May; 123(18):2791-6. PubMed ID: 24553177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
    Zanwar S; Abeykoon JP; Ansell SM; Gertz MA; Colby C; Larson D; Paludo J; He R; Warsame R; Greipp PT; King RL; Thompson CA; Witzig TE; Lacy MQ; Gonsalves W; Nowakowski GS; Dingli D; Go RS; Habermann TM; Vincent Rajkumar S; Kyle RA; Kumar S; Kapoor P
    Br J Haematol; 2021 Oct; 195(2):210-216. PubMed ID: 34340248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of Waldenström Macroglobulinemia in Korean Patients According to Mutational Status of MYD88 and CXCR4: Analysis Using Ultra-Deep Sequencing.
    Shin DW; Kim SM; Kim JA; Park HS; Hwang SM; Im K; Kim S; Kim J; Kwon S; Yoon SS; Lee DS
    Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e496-e505. PubMed ID: 31221512
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Alcoceba M; García-Álvarez M; Medina A; Maldonado R; González-Calle V; Chillón MC; Sarasquete ME; González M; García-Sanz R; Jiménez C
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
    Mailankody S; Landgren O
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare Circulating Cells in Familial Waldenström Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization.
    Pertesi M; Galia P; Nazaret N; Vallée M; Garderet L; Leleu X; Avet-Loiseau H; Foll M; Byrnes G; Lachuer J; McKay JD; Dumontet C
    PLoS One; 2015; 10(9):e0136505. PubMed ID: 26352266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity.
    Schmidt J; Federmann B; Schindler N; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
    Br J Haematol; 2015 Jun; 169(6):795-803. PubMed ID: 25819228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia.
    Moreno DF; Fernández de Larrea C
    Hematol Oncol Clin North Am; 2023 Aug; 37(4):659-670. PubMed ID: 37211494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.
    Jiménez C; Prieto-Conde MI; García-Álvarez M; Alcoceba M; Escalante F; Chillón MDC; García de Coca A; Balanzategui A; Cantalapiedra A; Aguilar C; Corral R; González-López T; Marín LA; Bárez A; Puig N; García-Mateo A; Gutiérrez NC; Sarasquete ME; González M; García-Sanz R
    Ann Hematol; 2018 Mar; 97(3):475-484. PubMed ID: 29353304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly Sensitive Detection Method of CXCR4 Tumor Hotspot Mutations by Drop-Off Droplet Digital PCR in Patients with IgM Monoclonal Gammopathies.
    Markou AN; Bagratuni T; Tsakiri C; Tserpeli V; Skourti S; Mavrianou Koutsoukou N; Papadimou A; Terpos E; Kastritis E; Lianidou E; Dimopoulos MA
    J Mol Diagn; 2023 Jul; 25(7):502-512. PubMed ID: 37088135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS.
    Schmidt K; Sack U; Graf R; Winkler W; Popp O; Mertins P; Sommermann T; Kocks C; Rajewsky K
    Front Immunol; 2020; 11():602868. PubMed ID: 33343574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgM monoclonal gammopathy of undetermined significance: clinicopathologic features with and without IgM-related disorders.
    Bruehl FK; Mannion P; Barbato E; Nakashima MO; Cook JR
    Haematologica; 2023 Oct; 108(10):2764-2773. PubMed ID: 37021542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MYD88
    Kapoor P
    Br J Haematol; 2019 Nov; 187(4):413-415. PubMed ID: 31298748
    [No Abstract]   [Full Text] [Related]  

  • 38.
    Yu X; Li W; Deng Q; Li L; Hsi ED; Young KH; Zhang M; Li Y
    Cancer Res; 2018 May; 78(10):2457-2462. PubMed ID: 29703722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK
    Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cellular origin and malignant transformation of Waldenström macroglobulinemia.
    Paiva B; Corchete LA; Vidriales MB; García-Sanz R; Perez JJ; Aires-Mejia I; Sanchez ML; Barcena P; Alignani D; Jimenez C; Sarasquete ME; Mateos MV; Ocio EM; Puig N; Escalante F; Hernández J; Cuello R; García de Coca A; Sierra M; Montes MC; González-López TJ; Galende J; Bárez A; Alonso J; Pardal E; Orfao A; Gutierrez NC; San Miguel JF
    Blood; 2015 Apr; 125(15):2370-80. PubMed ID: 25655603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.